Tolerance induction through non-avoidance to prevent persistent food allergy (TINA) in children and adults with peanut or tree nut allergy: rationale, study design and methods of a randomized controlled trial and observational cohort study

Tools

Tools

Tools

PubMed-IDs Bibliography MPEG-21 DIDL JSON RefWorks BibTeX Atom Simple Metadata Refer ASCII Citation Reference Manager Dublin Core HTML Citation EndNote

Preview	PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader 1MB
	Other (Supplementary Information) 50kB

Item Type:	Article
Title:	Tolerance induction through non-avoidance to prevent persistent food allergy (TINA) in children and adults with peanut or tree nut allergy: rationale, study design and methods of a randomized controlled trial and observational cohort study
Creators Name:	Trendelenburg, V., Dölle-Bierke, S., Unterleider, N., Alexiou, A., Kalb, B., Meixner, L., Heller, S., Lau, S., Lee, Y.A., Fauchère, F., Braun, J., Babina, M., Altrichter, S., Birkner, T., Roll, S., Dobbertin-Welsch, J., Worm, M. and Beyer, K.
Abstract:	BACKGROUND: Peanuts (PN) and tree nuts (TN) are among the most frequent elicitors of food allergy and can lead to life-threatening reactions. The current advice for allergic patients is to strictly avoid the offending food independently of their individual threshold level, whereas sensitized patients without allergic symptoms should frequently consume the food to avoid (re-)development of food allergy. The aim of this trial is to investigate (I) whether the consumption of low allergen amounts below the individual threshold may support natural tolerance development and (II) to what extent regular allergen consumption in sensitized but tolerant subjects prevents the (re-)development of PN or TN allergy. METHODS: The TINA trial consisting of (part I) a randomized, controlled, open, parallel group, single-center, superiority trial (RCT), and (part II) a prospective observational exploratory cohort study. Children and adults (age 1-67 years) with suspected or known primary PN and/or TN allergy will undergo an oral food challenge (OFC) to determine their clinical reactivity and individual threshold. In the RCT, 120 PN or TN allergic patients who tolerate ≥100 mg of food protein will be randomized (1:1 ratio) to consumption of products with low amounts of PN or TN on a regular basis or strict avoidance for 1 year. The consumption group will start with 1/100 of their individual threshold, increasing the protein amount to 1/50 and 1/10 after 4 and 8 months, respectively. The primary endpoint is the clinical tolerance to PN or TN after 1 year assessed by OFC. In the cohort study, 120 subjects sensitized to PN and/or TN but tolerant are advised to regularly consume the food and observed for 1 year. The primary endpoint is the maintenance of clinical tolerance to PN and/or TN after 1 year assessed by challenging with the former tolerated cumulative dose. DISCUSSION: This clinical trial will help to determine the impact of allergen consumption versus avoidance on natural tolerance development and whether the current dietary advice for PN or TN allergic patients with higher threshold levels is still valid. Trial registration: German Clinical Trials Register; ID: DRKS00016764 (RCT), DRKS00020467 (cohort study). Registered on 15 January 2020, http://www.drks.de .
Keywords:	Protocol, Randomized Controlled Trial, Peanut Allergy, Tree Nut Allergy, Elimination Diet, Higher Threshold, Oral Tolerance, Persistent Food Allergy
Source:	Trials
ISSN:	1745-6215
Publisher:	BioMed Central
Volume:	23
Number:	1
Page Range:	236
Date:	28 March 2022
Official Publication:	https://doi.org/10.1186/s13063-022-06149-4
PubMed:	View item in PubMed

Repository Staff Only: item control page

Download Statistics

Download Statistics

Download Statistics

Downloads

Downloads per month over past year